Table of Contents
ISRN Pediatrics
Volume 2012, Article ID 975685, 11 pages
http://dx.doi.org/10.5402/2012/975685
Review Article

Diabetic and Metabolic Programming: Mechanisms Altering the Intrauterine Milieu

1Medical Clinic and Policlinic IV, Ludwig Maximilian University of Munich, 80336 Munich, Germany
2Division of Endocrinology, Diabetes and Clinical Nutrition, University Hospital of Zurich, Raemistrasse 100, CH-8091 Zurich, Switzerland
3Institute for Automation and Systems Engineering, Ilmenau University of Technology, 98684 Ilmenau, Germany

Received 22 May 2012; Accepted 15 August 2012

Academic Editors: N. A. Shorter and K. Tokiwa

Copyright © 2012 Claudia Eberle and Christoph Ament. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. World Health Organization (WHO), http://www.who.int/mediacentre/factsheets/.
  2. D. S. Fernandez-Twinn and S. E. Ozanne, “Mechanisms by which poor early growth programs type-2 diabetes, obesity and the metabolic syndrome,” Physiology & Behavior, vol. 88, no. 3, pp. 234–243, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. D. J. P. Barker, “The developmental origins of chronic adult disease,” Acta Paediatrica, vol. 93, no. 446, pp. 26–33, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. C. N. Hales, D. J. P. Barker, P. M. S. Clark et al., “Fetal and infant growth and impaired glucose tolerance at age 64,” British Medical Journal, vol. 303, no. 6809, pp. 1019–1022, 1991. View at Google Scholar · View at Scopus
  5. D. J. P. Barker, “Fetal programming of coronary heart disease,” Trends in Endocrinology and Metabolism, vol. 13, no. 9, pp. 364–368, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. P. D. Gluckman and M. A. Hanson, “Maternal constraint of fetal growth and its consequences,” Seminars in Fetal & Neonatal Medicine, vol. 9, no. 5, pp. 419–425, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. A. C. J. Ravelli, J. H. P. van der Meulen, R. P. J. Michels et al., “Glucose tolerance in adults after prenatal exposure to famine,” The Lancet, vol. 351, no. 9097, pp. 173–177, 1998. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Bo, P. Cavallo-Perin, L. Scaglione, G. Ciccone, and G. Pagano, “Low birthweight and metabolic abnormalities in twins with increased susceptibility to type 2 diabetes mellitus,” Diabetic Medicine, vol. 17, no. 5, pp. 365–370, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Poulsen, K. O. Kyvik, A. Vaag, and H. Beck-Nielsen, “Heritability of type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance—a population-based twin study,” Diabetologia, vol. 42, no. 2, pp. 139–145, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Christensen, A. Wienke, A. Skytthe, N. V. Holm, J. W. Vaupel, and A. I. Yashin, “Cardiovascular mortality in twins and the fetal origins hypothesis,” Twin Research, vol. 4, no. 5, pp. 344–349, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Harder, E. Rodekamp, K. Schellong, J. W. Dudenhausen, and A. Plagemann, “Birth weight and subsequent risk of type 2 diabetes: a meta-analysis,” American Journal of Epidemiology, vol. 165, no. 8, pp. 849–857, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. C. A. Newsome, A. W. Shiell, C. H. D. Fall, D. I. W. Phillips, R. Shier, and C. M. Law, “Is birth weight related to later glucose and insulin metabolism?—A systematic review,” Diabetic Medicine, vol. 20, no. 5, pp. 339–348, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Oken and M. W. Gillman, “Fetal origins of obesity,” Obesity Research, vol. 11, no. 4, pp. 496–506, 2003. View at Google Scholar · View at Scopus
  14. R. S. Lindsay, R. M. Lindsay, B. J. Waddell, and J. R. Seckl, “Prenatal glucocorticoid exposure leads to offspring hyperglycaemia in the rat: studies with the 11 β-hydroxysteroid dehydrogenase inhibitor carbenoxolone,” Diabetologia, vol. 39, no. 11, pp. 1299–1305, 1996. View at Publisher · View at Google Scholar · View at Scopus
  15. R. A. Simmons, “Developmental origins of diabetes: the role of oxidative stress,” Free Radical Biology and Medicine, vol. 40, no. 6, pp. 917–922, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. C. J. Petry, M. W. Dorling, D. B. Pawlak, S. E. Ozanne, and C. N. Hales, “Diabetes in old male offspring of rat dams fed a reduced protein diet,” International Journal of Experimental Diabetes Research, vol. 2, no. 2, pp. 139–143, 2001. View at Google Scholar · View at Scopus
  17. J. M. Reinisch, N. G. Simon, W. G. Karow, and R. Gandelman, “Prenatal exposure to prednisone in humans and animals retards intrauterine growth,” Science, vol. 202, no. 4366, pp. 436–438, 1978. View at Google Scholar · View at Scopus
  18. B. Reusens and C. Remacle, “Programming of the endocrine pancreas by the early nutritional environment,” International Journal of Biochemistry and Cell Biology, vol. 38, no. 5-6, pp. 913–922, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Reusens, S. E. Ozanne, and C. Remacle, “Fetal determinants of type 2 diabetes,” Current Drug Targets, vol. 8, no. 8, pp. 935–941, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Boloker, S. J. Gertz, and R. A. Simmons, “Gestational diabetes leads to the development of diabetes in adulthood in the rat,” Diabetes, vol. 51, no. 5, pp. 1499–1506, 2002. View at Google Scholar · View at Scopus
  21. C. Nilsson, B. M. Larsson, E. Jennische et al., “Maternal endotoxemia results in obesity and insulin resistance in adult male offspring,” Endocrinology, vol. 142, no. 6, pp. 2622–2630, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. S. E. Ozanne, M. W. Dorling, C. L. Wang, and B. T. Nave, “Impaired PI 3-kinase activation in adipocytes from early growth-restricted male rats,” American Journal of Physiology, vol. 280, no. 3, pp. E534–E539, 2001. View at Google Scholar · View at Scopus
  23. J. Han, J. Xu, P. N. Epstein, and Y. Qui Liu, “Long-term effect of maternal obesity on pancreatic beta cells of offspring: reduced beta cell adaptation to high glucose and high-fat diet challenges in adult female mouse offspring,” Diabetologia, vol. 48, no. 9, pp. 1810–1818, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Holemans, L. Aerts, and F. A. van Assche, “Evidence for an insulin resistance in the adult offspring of pregnant streptozotocin-diabetic rats,” Diabetologia, vol. 34, no. 2, pp. 81–85, 1991. View at Google Scholar · View at Scopus
  25. J. A. Armitage, P. D. Taylor, and L. Poston, “Experimental models of developmental programming: consequences of exposure to an energy rich diet during development,” The Journal of Physiology, vol. 565, part 1, pp. 3–8, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Shankar, A. Harrell, X. Liu, J. M. Gilchrist, M. J. J. Ronis, and T. M. Badger, “Maternal obesity at conception programs obesity in the offspring,” American Journal of Physiology, vol. 294, no. 2, pp. R528–R538, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. M. H. Vickers, P. D. Gluckman, A. H. Coveny et al., “The effect of neonatal leptin treatment on postnatal weight gain in male rats is dependent on maternal nutritional status during pregnancy,” Endocrinology, vol. 149, no. 4, pp. 1906–1913, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. D. Dabelea and D. J. Pettitt, “Intrauterine diabetic environment confers risks for type 2 diabetes mellitus and obesity in the offspring, in addition to genetic susceptibility,” Journal of Pediatric Endocrinology and Metabolism, vol. 14, no. 8, pp. 1085–1091, 2001. View at Google Scholar · View at Scopus
  29. T. Lertbunnaphong, P. Talungjit, and V. Titapant, “Does gestational weight gain in normal pre-pregnancy BMI pregnant women reflect fetal weight gain?” Journal of the Medical Association of Thailand, vol. 95, no. 7, pp. 853–858, 2012. View at Google Scholar
  30. I. C. McMillen, L. J. Edwards, J. Duffield, and B. S. Muhlhausler, “Regulation of leptin synthesis and secretion before birth: implications for the early programming of adult obesity,” Reproduction, vol. 131, no. 3, pp. 415–427, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Beyerlein, I. Nehring, P. Rzehak et al., “Gestational weight gain and body mass index in children: results from three German cohort studies,” PLoS One, vol. 7, no. 3, Article ID e33205, 2012. View at Publisher · View at Google Scholar
  32. W. Palinski, F. P. D'Armiento, J. L. Witztum et al., “Maternal hypercholesterolemia and treatment during pregnancy influence the long-term progression of atherosclerosis in offspring of rabbits,” Circulation Research, vol. 89, no. 11, pp. 991–996, 2001. View at Google Scholar · View at Scopus
  33. T. Yamashita, S. Freigang, C. Eberle et al., “Maternal immunization programs postnatal immune responses and reduces atherosclerosis in offspring,” Circulation Research, vol. 99, no. 7, pp. E51–E64, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. C. L. Librach, S. L. Feigenbaum, K. E. Bass et al., “Interleukin-1β regulates human cytotrophoblast metalloproteinase activity and invasion in vitro,” The Journal of Biological Chemistry, vol. 269, no. 25, pp. 17125–17131, 1994. View at Google Scholar · View at Scopus
  35. C. Napoli, C. K. Glass, J. L. Witztum, R. Deutsch, F. P. D'Armiento, and W. Palinski, “Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: Fate of Early Lesions in Children (FELIC) study,” The Lancet, vol. 354, no. 9186, pp. 1234–1241, 1999. View at Publisher · View at Google Scholar · View at Scopus
  36. C. Napoli, F. P. D'Armiento, F. P. Mancini et al., “Fatty streak formation occurs in human fetal aortas and is greatly enhanced maternal, hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atheroeclerotic lesions,” The Journal of Clinical Investigation, vol. 100, no. 11, pp. 2680–2690, 1997. View at Google Scholar · View at Scopus
  37. A. Garofano, P. Czernichow, and B. Bréant, “In utero undernutrition impairs rat beta-cell development,” Diabetologia, vol. 40, no. 10, pp. 1231–1234, 1997. View at Publisher · View at Google Scholar · View at Scopus
  38. M. H. Vickers, B. A. Ikenasio, and B. H. Breier, “IGF-I treatment reduces hyperphagia, obesity, and hypertension in metabolic disorders induced by fetal programming,” Endocrinology, vol. 142, no. 9, pp. 3964–3973, 2001. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Snoeck, C. Remacle, B. Reusens, and J. J. Hoet, “Effect of a low protein diet during pregnancy on the fetal rat endocrine pancreas,” Biology of the Neonate, vol. 57, no. 2, pp. 107–118, 1990. View at Google Scholar · View at Scopus
  40. S. E. Ozanne, G. S. Olsen, L. L. Hansen et al., “Early growth restriction leads to down regulation of protein kinase C zeta and insulin resistance in skeletal muscle,” Journal of Endocrinology, vol. 177, no. 2, pp. 235–241, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Zamudio, S. K. Palmer, T. Droma, E. Stamm, C. Coffin, and L. G. Moore, “Effect of altitude on uterine artery blood flow during normal pregnancy,” Journal of Applied Physiology, vol. 79, no. 1, pp. 7–14, 1995. View at Google Scholar · View at Scopus
  42. N. O. Lunell, L. E. Nylund, R. Lewander, and B. Sarby, “Uteroplacental blood flow in pre-eclampsia measurements with indium-113m and a computer-linked gamma camera,” Clinical and Experimental Hypertension B, vol. 1, no. 1, pp. 105–117, 1982. View at Google Scholar · View at Scopus
  43. L. Myatt, “Placental adaptive responses and fetal programming,” The Journal of Physiology, vol. 572, part 1, pp. 25–30, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. G. Li, Y. Xiao, J. L. Estrella, C. A. Ducsay, R. D. Gilbert, and L. Zhang, “Effect of fetal hypoxia on heart susceptibility to ischemia and reperfusion injury in the adult rat,” Journal of the Society for Gynecologic Investigation, vol. 10, no. 5, pp. 265–274, 2003. View at Publisher · View at Google Scholar · View at Scopus
  45. J. Peyronnet, Y. Dalmaz, M. Ehrström et al., “Long-lasting adverse effects of prenatal hypoxia on developing autonomic nervous system and cardiovascular parameters in rats,” Pflügers Archiv, vol. 443, no. 5-6, pp. 858–865, 2002. View at Publisher · View at Google Scholar · View at Scopus
  46. D. O'Regan, C. J. Kenyon, J. R. Seckl, and M. C. Holmes, “Glucocorticoid exposure in late gestation in the rat permanently programs gender-specific differences in adult cardiovascular and metabolic physiology,” American Journal of Physiology, vol. 287, no. 5, pp. E863–E870, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. V. E. Murphy, R. Smith, W. B. Giles, and V. L. Clifton, “Endocrine regulation of human fetal growth: the role of the mother, placenta, and fetus,” Endocrine Reviews, vol. 27, no. 2, pp. 141–169, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. D. E. Challis, C. D. Pfarrer, J. W. K. Ritchie, G. Koren, and S. L. Adamson, “Glucose metabolism is elevated and vascular resistance and maternofetal transfer is normal in perfused placental cotyledons from severely growth-restricted fetuses,” Pediatric Research, vol. 47, no. 3, pp. 309–315, 2000. View at Google Scholar · View at Scopus
  49. T. Jansson, V. Scholtbach, and T. L. Powell, “Placental transport of leucine and lysine is reduced in intrauterine growth restriction,” Pediatric Research, vol. 44, no. 4, pp. 532–537, 1998. View at Google Scholar · View at Scopus
  50. G. Pardi, A. M. Marconi, and I. Cetin, “Placental-fetal interrelationship in IUGR fetuses—a review,” Placenta, vol. 23, pp. S136–S141, 2002. View at Publisher · View at Google Scholar · View at Scopus
  51. A. K. Karabulut, R. Layfield, and M. K. Pratten, “Growth promoting effects of human placental lactogen during early organogenesis: a link to insulin-like growth factors,” Journal of Anatomy, vol. 198, no. 6, pp. 651–662, 2001. View at Publisher · View at Google Scholar · View at Scopus
  52. L. A. Mucci, P. Lagiou, R. M. Tamimi, C. C. Hsieh, H. O. Adami, and D. Trichopoulos, “Pregnancy estriol, estradiol, progesterone and prolactin in relation to birth weight and other birth size variables (United States),” Cancer Causes and Control, vol. 14, no. 4, pp. 311–318, 2003. View at Publisher · View at Google Scholar · View at Scopus
  53. L. A. Mucci, P. Lagiou, C. C. Hsieh et al., “A prospective study of pregravid oral contraceptive use in relation to fetal growth,” BJOG: An International Journal of Obstetrics & Gynaecology, vol. 111, no. 9, pp. 989–995, 2004. View at Publisher · View at Google Scholar · View at Scopus
  54. A. Plagemann, I. Heidrich, F. Götz, W. Rohde, and G. Dörner, “Obesity and enhanced diabetes and cardiovascular risk in adult rats due to early postnatal overfeeding,” Experimental and Clinical Endocrinology, vol. 99, no. 3, pp. 154–158, 1992. View at Google Scholar · View at Scopus
  55. A. Plagemann, T. Harder, A. Rake et al., “Observations on the orexigenic hypothalamic neuropeptide Y-system in neonatally overfed weanling rats,” Journal of Neuroendocrinology, vol. 11, no. 7, pp. 541–546, 1999. View at Publisher · View at Google Scholar · View at Scopus
  56. A. Plagemann, H. Davidowa, T. Harder, and J. W. Dudenhausen, “Developmental programming of the hypothalamus: a matter of insulin. A comment on: Horvath, T. L., Bruning, J. C.: Developmental programming of the hypothalamus: a matter of fat. Nat. Med. (2006) 12: 52-53,” Neuroendocrinology Letters, vol. 27, no. 1-2, pp. 70–72, 2006. View at Google Scholar · View at Scopus
  57. A. Plagemann, “A matter of insulin: developmental programming of body weight regulation,” Journal of Maternal-Fetal and Neonatal Medicine, vol. 21, no. 3, pp. 143–148, 2008. View at Publisher · View at Google Scholar · View at Scopus
  58. I. Bogdarina, H. C. Murphy, S. P. Burns, and A. J. L. Clark, “Investigation of the role of epigenetic modification of the rat glucokinase gene in fetal programming,” Life Sciences, vol. 74, no. 11, pp. 1407–1415, 2004. View at Publisher · View at Google Scholar · View at Scopus
  59. A. J. Bennett, U. Sovio, A. Ruokonen et al., “Variation at the insulin gene VNTR (variable number tandem repeat) polymorphism and early growth: studies in a large Finnish birth cohort,” Diabetes, vol. 53, no. 8, pp. 2126–2131, 2004. View at Publisher · View at Google Scholar
  60. S. Hauguel-de Mouzon and M. Guerre-Millo, “The placenta cytokine network and inflammatory signals,” Placenta, vol. 27, no. 8, pp. 794–798, 2006. View at Publisher · View at Google Scholar · View at Scopus
  61. I. Juhan-Vague, M. C. Alessi, A. Mavri, and P. E. Morange, “Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk,” Journal of Thrombosis and Haemostasis, vol. 1, no. 7, pp. 1575–1579, 2003. View at Google Scholar · View at Scopus
  62. J. Barzilay and E. Freedland, “Inflammation and its association with glucose disorders and cardiovascular disease,” Treatments in Endocrinology, vol. 2, no. 2, pp. 85–94, 2003. View at Publisher · View at Google Scholar · View at Scopus
  63. J. Spranger, A. Kroke, M. Möhlig et al., “Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study,” Diabetes, vol. 52, no. 3, pp. 812–817, 2003. View at Publisher · View at Google Scholar · View at Scopus
  64. H. Xu, G. T. Barnes, Q. Yang et al., “Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance,” The Journal of Clinical Investigation, vol. 112, no. 12, pp. 1821–1830, 2003. View at Publisher · View at Google Scholar · View at Scopus
  65. P. J. Barnes and M. Karin, “Nuclear factor-κB—a pivotal transcription factor in chronic inflammatory diseases,” The New England Journal of Medicine, vol. 336, no. 15, pp. 1066–1071, 1997. View at Publisher · View at Google Scholar · View at Scopus
  66. H. P. Glauert, “Vitamin E and NF-kappaB activation: a review,” Vitamins & Hormones, vol. 76, pp. 135–153, 2007. View at Publisher · View at Google Scholar
  67. A. Zhou, S. Scoggin, R. B. Gaynor, and N. S. Williams, “Identification of NF-κB-regulated genes induced by TNFα utilizing expression profiling and RNA interference,” Oncogene, vol. 22, no. 13, pp. 2034–2044, 2003. View at Publisher · View at Google Scholar · View at Scopus
  68. M. Lappas, M. Permezel, H. M. Georgiou, and G. E. Rice, “Nuclear factor Kappa B regulation of proinflammatory cytokines in human gestational tissues in vitro,” Biology of Reproduction, vol. 67, no. 2, pp. 668–673, 2002. View at Google Scholar · View at Scopus
  69. J. P. Kirwan, S. Hauguel-de Mouzon, J. Lepercq et al., “TNF-α is a predictor of insulin resistance in human pregnancy,” Diabetes, vol. 51, no. 7, pp. 2207–2213, 2002. View at Publisher · View at Google Scholar · View at Scopus
  70. T. Cindrova-Davies, O. Spasic-Boskovic, E. Jauniaux, D. S. Charnock-Jones, and G. J. Burton, “Nuclear factor-κB, p38, and stress-activated protein kinase mitogen-activated protein kinase signaling pathways regulate proinflammatory cytokines and apoptosis in human placental explants in response to oxidative stress: effects of antioxidant vitamins,” The American Journal of Pathology, vol. 170, no. 5, pp. 1511–1520, 2007. View at Publisher · View at Google Scholar · View at Scopus
  71. J. Lepercq, M. Caüzac, N. Lahlou et al., “Overexpression of placental leptin in diabetic pregnancy: a critical role for insulin,” Diabetes, vol. 47, no. 5, pp. 847–850, 1998. View at Publisher · View at Google Scholar · View at Scopus
  72. E. Casanueva and F. E. Viteri, “Iron and oxidative stress in pregnancy,” The Journal of Nutrition, vol. 133, no. 5, pp. 1700S–1708S, 2003. View at Google Scholar · View at Scopus
  73. K. R. Page, The Physiology of Human Placenta, UCL Press, London, UK, 1993.
  74. H. Sies, Oxidative Stress II. Oxidants and Antioxidants, Academic Press, London, UK, 1991.
  75. A. K. Poranen, U. Ekblad, P. Uotila, and M. Ahotupa, “The effect of vitamin C and E on placental lipid peroxidation and antioxidative enzymes in perfused placenta,” Acta Obstetricia et Gynecologica Scandinavica, vol. 77, no. 4, pp. 372–376, 1998. View at Google Scholar · View at Scopus
  76. Y. P. Wang, S. W. Walsh, J. D. Guo, and J. Y. Zhang, “Maternal levels of prostacyclin, thromboxane, vitamin E, and lipid peroxides throughout normal pregnancy,” American Journal of Obstetrics and Gynecology, vol. 165, no. 6, part 1, pp. 1690–1694, 1991. View at Google Scholar · View at Scopus
  77. Y. Wang and S. W. Walsh, “Antioxidant activities and mRNA expression of superoxide dismutase, catalase, and glutathione peroxidase in normal and preeclamptic placentas,” Journal of the Society for Gynecologic Investigation, vol. 3, no. 4, pp. 179–184, 1996. View at Publisher · View at Google Scholar · View at Scopus
  78. T. Yoshioka, M. Ando, K. Taniguchi, F. Yamasaki, and H. Motoyama, “Lipoperoxidation and antioxidant substances in the human placenta during gestation,” Nippon Sanka Fujinka Gakkai Zasshi, vol. 42, no. 12, pp. 1634–1640, 1990. View at Google Scholar · View at Scopus
  79. R. Z. Fardoun, “The use of vitamin E in type 2 diabetes mellitus,” Clinical and Experimental Hypertension, vol. 29, no. 3, pp. 135–148, 2007. View at Publisher · View at Google Scholar · View at Scopus
  80. W. Kossenjans, A. Eis, R. Sahay, D. Brockman, and L. Myatt, “Role of peroxynitrite in altered fetal-placental vascular reactivity in diabetes or preeclampsia,” American Journal of Physiology, vol. 278, no. 4, pp. H1311–H1319, 2000. View at Google Scholar · View at Scopus
  81. R. Li, M. Chase, S. K. Jung, P. J. S. Smith, and M. R. Loeken, “Hypoxic stress in diabetic pregnancy contributes to impaired embryo gene expression and defective development by inducing oxidative stress,” American Journal of Physiology, vol. 289, no. 4, pp. E591–E599, 2005. View at Publisher · View at Google Scholar · View at Scopus
  82. J. M. Fernández-Real, A. López-Bermejo, and W. Ricart, “Cross-talk between iron metabolism and diabetes,” Diabetes, vol. 51, no. 8, pp. 2348–2354, 2002. View at Publisher · View at Google Scholar · View at Scopus
  83. T. T. Lao, K. F. Tam, and L. Y. Chan, “Third trimester iron status and pregnancy outcome in non-anaemic women; pregnancy unfavourably affected by maternal iron excess,” Human Reproduction, vol. 15, no. 8, pp. 1843–1848, 2000. View at Publisher · View at Google Scholar · View at Scopus
  84. E. Sivan, E. A. Reece, Y. K. Wu, C. J. Homko, M. Polansky, and M. Borenstein, “Dietary vitamin E prophylaxis and diabetic embryopathy: morphologic and biochemical analysis,” American Journal of Obstetrics & Gynecology, vol. 175, no. 4, part 1, pp. 793–799, 1996. View at Publisher · View at Google Scholar · View at Scopus
  85. J. A. Simoneau, S. R. Colberg, F. L. Thaete, and D. E. Kelley, “Skeletal muscle glycolitic and oxidative enzyme capacities are determinants of insulin sensitivity and muscle composition in obese women,” The FASEB Journal, vol. 9, no. 2, pp. 273–278, 1995. View at Google Scholar · View at Scopus
  86. S. Shah, M. Iqbal, J. Karam, M. Salifu, and S. I. McFarlane, “Oxidative stress, glucose metabolism, and the prevention of type 2 diabetes: pathophysiological insights,” Antioxidants and Redox Signaling, vol. 9, no. 7, pp. 911–929, 2007. View at Publisher · View at Google Scholar · View at Scopus
  87. M. A. Selak, B. T. Storey, I. Peterside, and R. A. Simmons, “Impaired oxidative phosphorylation in skeletal muscle of intrauterine growth-retarded rats,” American Journal of Physiology, vol. 285, no. 1, pp. E130–E137, 2003. View at Google Scholar · View at Scopus
  88. K. Morino, K. F. Petersen, and G. I. Shulman, “Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction,” Diabetes, vol. 55, no. 2, pp. S9–S15, 2006. View at Publisher · View at Google Scholar · View at Scopus
  89. U. J. Eriksson, “The pathogenesis of congenital malformations in diabetic pregnancy,” Diabetes/Metabolism Reviews, vol. 11, no. 1, pp. 63–82, 1995. View at Google Scholar · View at Scopus
  90. E. A. Reece, C. J. Homko, and Y. K. Wu, “Multifactorial basis of the syndrome of diabetic embryopathy,” Teratology, vol. 54, no. 4, pp. 171–182, 1996. View at Google Scholar
  91. M. Horal, Z. Zhang, R. Stanton, A. Virkamäki, and M. R. Loeken, “Activation of the hexosamine pathway causes oxidative stress and abnormal embryo gene expression: involvement in diabetic teratogenesis,” Birth Defects Research A, vol. 70, no. 8, pp. 519–527, 2004. View at Publisher · View at Google Scholar · View at Scopus
  92. M. Kiely, P. A. Morrissey, P. F. Cogan, and P. J. Kearney, “Low molecular weight plasma antioxidants and lipid peroxidation in maternal and cord blood,” European Journal of Clinical Nutrition, vol. 53, no. 11, pp. 861–864, 1999. View at Google Scholar · View at Scopus
  93. R. Robles, N. Palomino, and A. Robles, “Oxidative stress in the neonate,” Early Human Development, vol. 65, supplement 2, pp. S75–S81, 2001. View at Publisher · View at Google Scholar · View at Scopus
  94. C. Gicquel, A. El-Osta, and Y. Le Bouc, “Epigenetic regulation and fetal programming,” Best Practice and Research in Clinical Endocrinology and Metabolism, vol. 22, no. 1, pp. 1–16, 2008. View at Publisher · View at Google Scholar · View at Scopus
  95. R. A. Simmons, “Developmental origins of diabetes: the role of epigenetic mechanisms,” Current Opinion in Endocrinology, Diabetes and Obesity, vol. 14, no. 1, pp. 13–16, 2007. View at Publisher · View at Google Scholar · View at Scopus
  96. C. A. Cooney, A. A. Dave, and G. L. Wolff, “Maternal methyl supplements in mice affect epigenetic variation and DNA methylation of offspring,” The Journal of Nutrition, vol. 132, no. 8, supplement, pp. 2393S–2400S, 2002. View at Google Scholar · View at Scopus
  97. J. F. Costello, M. C. Fruhwald, D. J. Smiragtia et al., “Aberrant CpG-island methylation has nonrandom and tumour-type-specific patterns,” Nature Genetics, vol. 24, no. 2, pp. 132–138, 2000. View at Google Scholar
  98. O. Galm, H. Yoshikawa, M. Esteller, R. Osieka, and J. G. Herman, “SOCS-1, a negative regulator of cytokine signaling, is frequently silenced by methylation in multiple myeloma,” Blood, vol. 101, no. 7, pp. 2784–2788, 2003. View at Publisher · View at Google Scholar · View at Scopus